vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and TACTILE SYSTEMS TECHNOLOGY INC (TCMD). Click either name above to swap in a different company.
TACTILE SYSTEMS TECHNOLOGY INC is the larger business by last-quarter revenue ($103.6M vs $83.1M, roughly 1.2× PROCEPT BioRobotics Corp). TACTILE SYSTEMS TECHNOLOGY INC runs the higher net margin — 10.3% vs -38.1%, a 48.3% gap on every dollar of revenue. On growth, TACTILE SYSTEMS TECHNOLOGY INC posted the faster year-over-year revenue change (21.0% vs 20.2%). Over the past eight quarters, TACTILE SYSTEMS TECHNOLOGY INC's revenue compounded faster (30.2% CAGR vs 24.8%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Dominion Voting Systems Corporation was a North American company that produced and sold electronic voting hardware and software, including voting machines and tabulators, in Canada and the United States.
PRCT vs TCMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.1M | $103.6M |
| Net Profit | $-31.6M | $10.6M |
| Gross Margin | 64.9% | 78.2% |
| Operating Margin | -4.1% | 18.1% |
| Net Margin | -38.1% | 10.3% |
| Revenue YoY | 20.2% | 21.0% |
| Net Profit YoY | -27.9% | 9.4% |
| EPS (diluted) | $-0.56 | $0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | — | ||
| Q4 25 | $76.4M | $103.6M | ||
| Q3 25 | $83.3M | $85.8M | ||
| Q2 25 | $79.2M | $78.9M | ||
| Q1 25 | $69.2M | $61.3M | ||
| Q4 24 | $68.2M | $85.6M | ||
| Q3 24 | $58.4M | $73.1M | ||
| Q2 24 | $53.4M | $73.2M |
| Q1 26 | $-31.6M | — | ||
| Q4 25 | $-29.8M | $10.6M | ||
| Q3 25 | $-21.4M | $8.2M | ||
| Q2 25 | $-19.6M | $3.2M | ||
| Q1 25 | $-24.7M | $-3.0M | ||
| Q4 24 | $-18.9M | $9.7M | ||
| Q3 24 | $-21.0M | $5.2M | ||
| Q2 24 | $-25.6M | $4.3M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | 78.2% | ||
| Q3 25 | 64.8% | 75.8% | ||
| Q2 25 | 65.4% | 74.5% | ||
| Q1 25 | 63.9% | 74.0% | ||
| Q4 24 | 64.0% | 75.2% | ||
| Q3 24 | 63.2% | 75.0% | ||
| Q2 24 | 59.0% | 73.9% |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | 18.1% | ||
| Q3 25 | -27.8% | 12.8% | ||
| Q2 25 | -28.0% | 5.2% | ||
| Q1 25 | -39.7% | -7.4% | ||
| Q4 24 | -28.9% | 14.6% | ||
| Q3 24 | -38.4% | 9.3% | ||
| Q2 24 | -50.3% | 8.0% |
| Q1 26 | -38.1% | — | ||
| Q4 25 | -39.1% | 10.3% | ||
| Q3 25 | -25.7% | 9.6% | ||
| Q2 25 | -24.7% | 4.1% | ||
| Q1 25 | -35.8% | -4.9% | ||
| Q4 24 | -27.6% | 11.4% | ||
| Q3 24 | -35.9% | 7.1% | ||
| Q2 24 | -48.0% | 5.9% |
| Q1 26 | $-0.56 | — | ||
| Q4 25 | $-0.54 | $0.45 | ||
| Q3 25 | $-0.38 | $0.36 | ||
| Q2 25 | $-0.35 | $0.14 | ||
| Q1 25 | $-0.45 | $-0.13 | ||
| Q4 24 | $-0.34 | $0.40 | ||
| Q3 24 | $-0.40 | $0.21 | ||
| Q2 24 | $-0.50 | $0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $83.4M |
| Total DebtLower is stronger | $51.7M | $0 |
| Stockholders' EquityBook value | $347.7M | $218.9M |
| Total Assets | $487.1M | $273.9M |
| Debt / EquityLower = less leverage | 0.15× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | $83.4M | ||
| Q3 25 | $294.3M | $66.0M | ||
| Q2 25 | $302.7M | $81.5M | ||
| Q1 25 | $316.2M | $83.6M | ||
| Q4 24 | $333.7M | $94.4M | ||
| Q3 24 | $196.8M | $82.1M | ||
| Q2 24 | $214.1M | $73.6M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | $0 | ||
| Q3 25 | $51.6M | $0 | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | $51.4M | $27.0M | ||
| Q2 24 | $51.4M | $27.8M |
| Q1 26 | $347.7M | — | ||
| Q4 25 | $365.9M | $218.9M | ||
| Q3 25 | $380.3M | $204.9M | ||
| Q2 25 | $385.8M | $194.9M | ||
| Q1 25 | $389.2M | $205.6M | ||
| Q4 24 | $402.2M | $216.6M | ||
| Q3 24 | $241.2M | $207.9M | ||
| Q2 24 | $251.8M | $200.7M |
| Q1 26 | $487.1M | — | ||
| Q4 25 | $508.1M | $273.9M | ||
| Q3 25 | $511.5M | $259.2M | ||
| Q2 25 | $513.1M | $273.0M | ||
| Q1 25 | $519.4M | $280.2M | ||
| Q4 24 | $534.0M | $297.9M | ||
| Q3 24 | $374.1M | $287.7M | ||
| Q2 24 | $374.4M | $278.8M |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | 0.00× | ||
| Q3 25 | 0.14× | 0.00× | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | 0.13× | ||
| Q2 24 | 0.20× | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $17.3M |
| Free Cash FlowOCF − Capex | — | $16.8M |
| FCF MarginFCF / Revenue | — | 16.2% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | 1.63× |
| TTM Free Cash FlowTrailing 4 quarters | — | $40.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.3M | $17.3M | ||
| Q3 25 | $-6.6M | $10.3M | ||
| Q2 25 | $-15.0M | $14.8M | ||
| Q1 25 | $-17.0M | $417.0K | ||
| Q4 24 | $-32.4M | $16.3M | ||
| Q3 24 | $-18.8M | $10.3M | ||
| Q2 24 | $-15.7M | $13.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-12.2M | $16.8M | ||
| Q3 25 | $-9.5M | $9.2M | ||
| Q2 25 | $-17.8M | $14.4M | ||
| Q1 25 | $-18.8M | $38.0K | ||
| Q4 24 | $-33.6M | $15.9M | ||
| Q3 24 | $-19.0M | $9.3M | ||
| Q2 24 | $-16.8M | $12.6M |
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | 16.2% | ||
| Q3 25 | -11.4% | 10.8% | ||
| Q2 25 | -22.5% | 18.2% | ||
| Q1 25 | -27.2% | 0.1% | ||
| Q4 24 | -49.2% | 18.5% | ||
| Q3 24 | -32.6% | 12.7% | ||
| Q2 24 | -31.4% | 17.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 0.5% | ||
| Q3 25 | 3.4% | 1.3% | ||
| Q2 25 | 3.5% | 0.5% | ||
| Q1 25 | 2.7% | 0.6% | ||
| Q4 24 | 1.7% | 0.5% | ||
| Q3 24 | 0.4% | 1.3% | ||
| Q2 24 | 2.0% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 4.59× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.68× | ||
| Q3 24 | — | 1.99× | ||
| Q2 24 | — | 3.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
TCMD
| Private Insurers | $57.6M | 56% |
| Medicare | $24.6M | 24% |
| Durable Medical Equipment Distributors | $14.1M | 14% |
| Veterans Administration | $7.3M | 7% |
